These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 32306854)
1. Novel guanosine derivatives against MERS CoV polymerase: An Elfiky AA; Azzam EB J Biomol Struct Dyn; 2021 May; 39(8):2923-2931. PubMed ID: 32306854 [TBL] [Abstract][Full Text] [Related]
2. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. Gordon CJ; Tchesnokov EP; Feng JY; Porter DP; Götte M J Biol Chem; 2020 Apr; 295(15):4773-4779. PubMed ID: 32094225 [TBL] [Abstract][Full Text] [Related]
3. Computational modeling of the bat HKU4 coronavirus 3CL Abuhammad A; Al-Aqtash RA; Anson BJ; Mesecar AD; Taha MO J Mol Recognit; 2017 Nov; 30(11):. PubMed ID: 28608547 [TBL] [Abstract][Full Text] [Related]
4. Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking. Elghoneimy LK; Ismail MI; Boeckler FM; Azzazy HME; Ibrahim TM Comput Biol Med; 2021 Jul; 134():104468. PubMed ID: 34015671 [TBL] [Abstract][Full Text] [Related]
5. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326 [TBL] [Abstract][Full Text] [Related]
7. A Cell-Based Reporter Assay for Screening Inhibitors of MERS Coronavirus RNA-Dependent RNA Polymerase Activity. Min JS; Kim GW; Kwon S; Jin YH J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32727069 [TBL] [Abstract][Full Text] [Related]
8. M RK; Gideon DA; Mariadasse R; Nirusimhan V; A SR; Edward JC; Jeyaraman J; Dhayabaran V J Biomol Struct Dyn; 2022 Sep; 40(15):6710-6724. PubMed ID: 33615998 [TBL] [Abstract][Full Text] [Related]
9. Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS. Tomar S; Johnston ML; St John SE; Osswald HL; Nyalapatla PR; Paul LN; Ghosh AK; Denison MR; Mesecar AD J Biol Chem; 2015 Aug; 290(32):19403-22. PubMed ID: 26055715 [TBL] [Abstract][Full Text] [Related]
10. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants. Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425 [TBL] [Abstract][Full Text] [Related]
11. Assessment of proton-coupled conformational dynamics of SARS and MERS coronavirus papain-like proteases: Implication for designing broad-spectrum antiviral inhibitors. Henderson JA; Verma N; Harris RC; Liu R; Shen J J Chem Phys; 2020 Sep; 153(11):115101. PubMed ID: 32962355 [TBL] [Abstract][Full Text] [Related]
12. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study. Wakchaure PD; Ghosh S; Ganguly B J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493 [TBL] [Abstract][Full Text] [Related]